Medical News

RSS

Medtronic launches Tri-Ad ring for tricuspid valve disease

Medtronic, Inc. today announced the global launch and first clinical use of the Tri-Ad Semi-Flexible Tricuspid Annuloplasty Ring for the treatment of tricuspid valve disease.

19 Nov 2010

KHN column -- the Texas Medicaid scenario: Why it's never going to happen

When I first heard about this controversy, I noted one simple fact that deserves greater play: This is not going to happen. Withdrawing from Medicaid would be political suicide.

19 Nov 2010

Spectrum to present four key belinostat data for solid cancers at ASH annual meeting

Spectrum Pharmaceuticals, Inc., a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology, today announced four key belinostat data presentations at the 52nd Annual Meeting of the American Society of Hematology (ASH), being held at the Orange County Convention Center in Orlando, Florida, December 4-7, 2010.

19 Nov 2010

HSR Act applicable to LabCorp’s acquisition of Genzyme

Laboratory Corporation of America Holdings today announced that it has received early termination from the Federal Trade Commission of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, or HSR Act, applicable to the acquisition of Genzyme Genetics, a business unit of Genzyme Corp. by LabCorp.

19 Nov 2010

Sec. of State Clinton begins discussing QDDR draft with U.S. lawmakers

Secretary of State Hillary Rodham Clinton began rolling out her long-awaited revamp of U.S. diplomatic strategy on Wednesday, meeting lawmakers to discuss the 'Quadrennial Diplomacy and Development Review' (QDDR) that is expected to be formally announced later this year, Reuters reports.

19 Nov 2010

Impax announces positive top-line results of Phase III IPX066 study for Parkinson's disease

Impax Pharmaceuticals, the brand products division of Impax Laboratories, Inc., today announced positive top-line results of the APEX-PD Phase III clinical study with IPX066 in Parkinson's disease (PD). IPX066 is a novel extended release carbidopa-levodopa product.

19 Nov 2010

Ethicon submits BLA to FDA for Fibrin Pad

Ethicon, Inc., a worldwide leader in surgical care, announced today that the company has submitted a Biologic License Application (BLA) to the U.S. Food and Drug Administration (FDA) for the Fibrin Pad, a novel product candidate that combines Ethicon's biomaterials and plasma-derived biologics (Human Fibrinogen and Human Thrombin), to aid in stopping soft tissue bleeding during surgery.

19 Nov 2010

Elorac announces results of Phase III CPO solution studies for acne at Healthcare Conference in New York

Elorac, Inc., a rapidly growing specialty pharmaceutical company focused on the treatment of dermatological disorders, announced results of two Phase III studies of its patented Carbamide Peroxide (CPO) solution for the treatment of inflammatory acne vulgaris and rosacea at the Lazard Capital Markets 7th Annual Healthcare Conference in New York.

19 Nov 2010

Cardinal Health announces plan to acquire Kinray

Cardinal Health today announced plans to acquire Kinray, Inc., a leading pharmaceutical distributor serving the New York metropolitan area, for $1.3 billion in an all-cash transaction that will significantly expand its ability to serve retail independent pharmacies in the northeastern United States.

19 Nov 2010

Berwick's first hearing marked by strong defense of health law, GOP 'relative gentleness'

Centers for Medicare and Medicaid Services chief Dr. Donald Berwick survived his first Senate hearing yesterday by rebutting criticism of the health law and because Republicans were relatively gentle, The New York Times reports.

19 Nov 2010

Sekisui enters asset purchase agreement to acquire Genzyme's Diagnostic products

Genzyme Corporation today announced that it has entered into an asset purchase agreement under which Sekisui Chemical Co., Ltd. will acquire Genzyme's Diagnostic products business for $265 million in cash.

19 Nov 2010

Cerulean presents data on CRLX101, CRLX288 study for cancer at EORTC-NCI-AACR Symposium

Cerulean Pharma Inc., a leader in designing and developing nanopharmaceuticals, today announced that the Company's senior executives presented at the 22nd EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics, ongoing in Berlin, Germany.

19 Nov 2010

FDA approves IDE application for Home Hemodialysis system

Baxter International Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved an Investigational Device Exemption (IDE) application for a Home Hemodialysis (HD) system in development through a collaboration between DEKA Research and Development Corp., HHD LLC, and Baxter.

From Baxter International Inc. 19 Nov 2010

Bipartisan task force recommends Medicare and Medicaid overhaul

Congress must overhaul Medicare and Medicaid and end tax-free health coverage to help bring the federal debt to manageable levels, a bipartisan task force said Wednesday.

19 Nov 2010

Alnylam presents data on RNAi technologies at MIT Center Summit

Alnylam Biotherapeutics, a division of Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, presented new data at the MIT Center for Biomedical Innovation's Biomanufacturing Summit from its platform efforts aimed at developing RNAi technologies for applications in biologics manufacturing.

19 Nov 2010

FDA approves new drug application for NEXTERONE Premixed Injection

Prism Pharmaceuticals, Inc. announced today that the U.S. Food & Drug Administration has approved the supplemental new drug application for NEXTERONE (amiodarone HCl) Premixed Injection, the first and only premixed intravenous (IV) bag formulation of the antiarrhythmic agent amiodarone IV.

19 Nov 2010

Cholera confirmed in Florida woman who traveled to Haiti

"The first known case of cholera in the United States linked to the outbreak in Haiti was confirmed Wednesday by health officials who said a southwest Florida woman contracted the disease while visiting family in a region at the heart of Haiti's epidemic," the New York Times reports.

19 Nov 2010

Expert panel to endorse newly approved therapeutic vaccine for advanced prostate cancer

Provenge is one step closer to being covered by Medicare. An expert panel voted Wednesday to endorse the newly approved therapeutic vaccine for men with advanced prostate cancer.

19 Nov 2010

New findings show promising treatment for MS

Successfully treating and reversing the effects of multiple sclerosis, or MS, may one day be possible using a drug originally developed to treat chronic pain, according to Distinguished Professor Linda Watkins of the University of Colorado at Boulder.

19 Nov 2010

Health law revision suggestions pour in from lawmakers, groups

Kaiser Health News reports that vulnerable Democrats are looking for alternatives to the health law's mandate that nearly all Americans carry health insurance. "Under political pressure as a result of the new health law, Sen. Ben Nelson, D-Neb., has asked the Government Accountability Office to study alternatives to the controversial mandate requiring most Americans to obtain coverage." Because Nelson is from a typically "red" state, Republicans have targeted him as one Democrat willing to play ball on scaling back the law (Vaida, 11/17).

19 Nov 2010

Medical News

Medtronic launches Tri-Ad ring for tricuspid valve disease

KHN column -- the Texas Medicaid scenario: Why it's never going to happen

Spectrum to present four key belinostat data for solid cancers at ASH annual meeting

HSR Act applicable to LabCorp’s acquisition of Genzyme

Sec. of State Clinton begins discussing QDDR draft with U.S. lawmakers

Impax announces positive top-line results of Phase III IPX066 study for Parkinson's disease

Ethicon submits BLA to FDA for Fibrin Pad

Elorac announces results of Phase III CPO solution studies for acne at Healthcare Conference in New York

Cardinal Health announces plan to acquire Kinray

Berwick's first hearing marked by strong defense of health law, GOP 'relative gentleness'

Sekisui enters asset purchase agreement to acquire Genzyme's Diagnostic products

Cerulean presents data on CRLX101, CRLX288 study for cancer at EORTC-NCI-AACR Symposium

FDA approves IDE application for Home Hemodialysis system

Bipartisan task force recommends Medicare and Medicaid overhaul

Alnylam presents data on RNAi technologies at MIT Center Summit

FDA approves new drug application for NEXTERONE Premixed Injection

Cholera confirmed in Florida woman who traveled to Haiti

Expert panel to endorse newly approved therapeutic vaccine for advanced prostate cancer

New findings show promising treatment for MS

Health law revision suggestions pour in from lawmakers, groups

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News